Design CDRs with improved binding affinity
Antigen | IgDesign (HCDR3) | IgDesign (HCDR123) | SAbDab (HCDR3) |
---|---|---|---|
Antigen 1 | 30.6% (22/72) | 6.3% (4/64) | 1.6% (1/61) |
IL36R | 27.9% (19/68) | 15.6% (5/32) | 1.6% (1/68) |
C5 | 53.8% (14/26) | 61.5% (8/13) | 16.7% (1/6) |
TSLP | 96.3% (52/54) | 92.2% (47/51) | 88.1% (37/42) |
IL17A | 56.3% (9/16) | 0.0% (0/8) | 12.5% (1/8) |
FXI | 61.5% (32/52) | 49.0% (24/49) | 20.0% (1/5) |
ACVR2B | 53.3% (16/30) | 9.4% (3/32) | 0.0% (0/9) |
TNFRSF9 | 22.4% (15/67) | 24.3% (9/37) | 6.3% (2/32) |